Unlock stock picks and a broker-level newsfeed that powers Wall Street.

LSE - Delayed Quote USD

Intuitive Surgical, Inc. (0R29.L)

Compare
490.09
+1.09
+(0.22%)
At close: April 11 at 7:14:55 PM GMT+1
Loading Chart for 0R29.L
  • Previous Close 489.00
  • Open 496.13
  • Bid --
  • Ask --
  • Day's Range 481.54 - 496.13
  • 52 Week Range 232.27 - 496.13
  • Volume 1,553
  • Avg. Volume 4,888
  • Market Cap (intraday) 56.273B
  • Beta (5Y Monthly) 1.56
  • PE Ratio (TTM) 1.09
  • EPS (TTM) 4.49
  • Earnings Date Apr 23, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

www.intuitive.com

15,638

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0R29.L

View More

Performance Overview: 0R29.L

Trailing total returns as of 4/12/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

0R29.L
7.17%
MSCI WORLD (^990100-USD-STRD)
6.38%

1-Year Return

0R29.L
24.98%
MSCI WORLD (^990100-USD-STRD)
3.59%

3-Year Return

0R29.L
74.14%
MSCI WORLD (^990100-USD-STRD)
17.28%

5-Year Return

0R29.L
197.50%
MSCI WORLD (^990100-USD-STRD)
0.00%

Compare To: 0R29.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0R29.L

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    27.81%

  • Return on Assets (ttm)

    8.67%

  • Return on Equity (ttm)

    15.62%

  • Revenue (ttm)

    8.35B

  • Net Income Avi to Common (ttm)

    2.32B

  • Diluted EPS (ttm)

    4.49

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.01B

  • Total Debt/Equity (mrq)

    0.88%

  • Levered Free Cash Flow (ttm)

    1.2B

Research Analysis: 0R29.L

View More

Company Insights: 0R29.L

Research Reports: 0R29.L

View More

People Also Watch